Our findings indicate that resveratrol pharmacologically activates PPAR-γ, downregulates the expression of inflammatory cytokine proteins such as NF-κB and IL-6, and alleviates liver and gallbladder inflammation. The gene discussed is PPARG; the disease is Cholecystitis.